Beta Drugs Ltd vs Divis Laboratories Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Beta Drugs Ltd currently has the stronger revenue growth signal.
Beta Drugs Ltd and Divis Laboratories Ltd show active capex signals based on earnings call analysis.
Beta Drugs Ltd show fundraising activity or capital structure signals.
| Metric | Beta Drugs Ltd | Divis Laboratories Ltd |
|---|---|---|
| Current Price | ₹2,365 | ₹8,378 |
| Market Cap | ₹1,289.31 Cr. | ₹1.78 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 31.08 | 70.32 |
| ROE (%) | 18.78 | 15.35 |
| Debt/Equity | 0.6 | 0.01 |
| Sales Growth 5Y (%) | 27.08 | 11.65 |
| Profit Growth 5Y (%) | 19.22 | 1.47 |
| Promoter Holding (%) | 2.15 | 19.13 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 2 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | Yes | No information |